Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction of Heme Oxygenase-1 to reduce hepatic ischaemia-reperfusion injury in liver surgery
2008-005955-40Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of heme arginate in hepatic ischemia-reperfusion injury (HIRI), sponsored by University of Edinburgh. Primary endpoints: Induction of heme oxygenase-1 (HO-1) in liver tissue and Induction of heme oxygenase-1 (HO-1) in circulating monocytes. Started Apr 2009; status: completed.
02
Drugs
heme arginate
03
Conditions
hepatic ischemia-reperfusion injury (HIRI)
Beyond the preview
Go deeper on 2008-005955-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005955-40.